Edition:
India

Insider Trading: Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

11.11USD
13 Nov 2019
Change (% chg)

-- (--)
Prev Close
$11.11
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
38,627
52-wk High
$34.65
52-wk Low
$10.04

All Insider Trades
Trading Date Name Title Type Shares Traded Price
27 Sep 2019

Soland (Daniel B)

Director Buy 7,962 $11.87
26 Sep 2019

Soland (Daniel B)

Director Buy 2,038 $11.90
29 Jul 2019

Cha (Albert)

Director Buy 5,137 $17.13
29 Jul 2019

Cha (Albert)

Director Buy 24,730 $17.13
26 Jul 2019

Cha (Albert)

Director Buy 4,558 $16.83
26 Jul 2019

Cha (Albert)

Director Buy 21,942 $16.83
23 Jul 2019

Feener (Edward P)

Officer Sell 1,900 $18.65
22 Jul 2019

Feener (Edward P)

Officer Sell 1,400 $18.57
22 Jul 2019

Yea (Christopher M Ph.D.)

Officer Sell 7,355 $18.35
22 Jul 2019

Yea (Christopher M Ph.D.)

Officer Buy 7,355 $0.00
19 Jul 2019

Cha (Albert)

Director Buy 49,680 $17.84
19 Jul 2019

Cha (Albert)

Director Buy 10,320 $17.68
17 Jul 2019

Cha (Albert)

Director Buy 1,060 $16.97
17 Jul 2019

Cha (Albert)

Director Buy 220 $16.93
15 Jul 2019

Crockett (Thomas Andrew)

Chief Executive Officer Sell 10,000 $17.04
22 Apr 2019

Yea (Christopher M Ph.D.)

Officer Sell 6,355 $25.92
22 Apr 2019

Palleiko (Benjamin L)

Chief Financial Officer Buy 2,000 $8.39
22 Apr 2019

Palleiko (Benjamin L)

Chief Financial Officer Sell 2,000 $25.80
22 Apr 2019

Yea (Christopher M Ph.D.)

Officer Buy 7,355 $0.00
22 Apr 2019

Yea (Christopher M Ph.D.)

Officer Sell 1,000 $26.79
18 Apr 2019

Palleiko (Benjamin L)

Chief Financial Officer Sell 1,073 $25.51
18 Apr 2019

Palleiko (Benjamin L)

Chief Financial Officer Buy 1,073 $6.74
17 Apr 2019

Feener (Edward P)

Officer Sell 3,084 $24.78
17 Apr 2019

Feener (Edward P)

Officer Sell 916 $25.39
15 Apr 2019

Crockett (Thomas Andrew)

Chief Executive Officer Sell 300 $25.92

Institutional Holders

% Shares Owned: 89.35%
# of Holders: 118
Total Shares Held: 15,917,831
3 Mo. Net Change: 221,663
# New Positions: 17
# Closed Positions: 9
# Increased Positions: 36
# Reduced Positions: 17
# Net Buyers: 19

Officers & Directors

Name Age Since Current Position

Thomas Crockett

43 2016 Chief Executive Officer, Director

Benjamin Palleiko

52 2019 Chief Financial Officer, Chief Business Officer

Andreas Maetzel

54 2017 Senior Vice President, Medical

Edward Feener

57 2016 Chief Scientific Officer

Christopher Yea

55 2016 Chief Development Officer

Martin Edwards

62 2019 Director

Brian Pereira

59 2019 Director

Daniel Soland

60 2019 Director

Albert Cha

46 2007 Independent Director

Arnold Oronsky

78 2016 Independent Director

Edward Unkart

68 2014 Independent Director